The aPL tests included in the revised criteria for APS classification are: anti-cardiolipin (aCL) and anti-β2 glycoprotein I (aβ2GPI) antibodies, and the lupus anticoagulant (LA); their presence should be confirmed at least 12 weeks apart. Here, FASLG is linked to autoimmune polyendocrinopathy.